Pseudotumor Cerebri Headache Ten Years Outcome
Headache Long Term Follow-up in Patients Who Suffered From PTCS During Their Childhood
1 other identifier
observational
100
1 country
1
Brief Summary
Telephone interview on patient who suffered from PTC ten years ago regarding their headache status
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedFirst Posted
Study publicly available on registry
September 3, 2024
CompletedSeptember 3, 2024
August 1, 2024
2 months
August 27, 2024
August 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
headache outcome HIT-6
How many patients will suffer from headache after recovery from PTC measured by HIT 6 questionnaire
5-10 years
Secondary Outcomes (1)
Quality of life (QOL)
5-10 years
Study Arms (1)
Research
Patients who were diagnosed with PTC as children
Eligibility Criteria
Adults who were diagnosed with Ptc at their childhood .
You may qualify if:
- Patients who were diagnosed with PTC as children
You may not qualify if:
- Patients has other headache types other than PTC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bani Zion
Haifa, Israel
Related Publications (7)
Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985 Mar;5(1):55-6. No abstract available.
PMID: 3156890RESULTKesler A, Bassan H. Pseudotumor cerebri - idiopathic intracranial hypertension in the pediatric population. Pediatr Endocrinol Rev. 2006 Jun;3(4):387-92.
PMID: 16816807RESULTBuchheit WA, Burton C, Haag B, Shaw D. Papilledema and idiopathic intracranial hypertension. N Engl J Med. 1969 Apr 24;280(17):938-42. doi: 10.1056/NEJM196904242801707. No abstract available.
PMID: 5775633RESULTFriedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002 Nov 26;59(10):1492-5. doi: 10.1212/01.wnl.0000029570.69134.1b.
PMID: 12455560RESULTBaker RS, Baumann RJ, Buncic JR. Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients. Pediatr Neurol. 1989 Jan-Feb;5(1):5-11. doi: 10.1016/0887-8994(89)90002-7.
PMID: 2653341RESULTCouch R, Camfield PR, Tibbles JA. The changing picture of pseudotumor cerebri in children. Can J Neurol Sci. 1985 Feb;12(1):48-50. doi: 10.1017/s0317167100046588.
PMID: 3978475RESULTDhiravibulya K, Ouvrier R, Johnston I, Procopis P, Antony J. Benign intracranial hypertension in childhood: a review of 23 patients. J Paediatr Child Health. 1991 Oct;27(5):304-7. doi: 10.1111/j.1440-1754.1991.tb02544.x.
PMID: 1931224RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
jacob Genizi
Bnai Zion Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2024
First Posted
September 3, 2024
Study Start
July 1, 2024
Primary Completion
August 31, 2024
Study Completion
August 31, 2024
Last Updated
September 3, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share